Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer.

Thara, Eddie; Dorff, Tanya B; Pinski, Jacek K; Quinn, David I

Thara, Eddie; Dorff, Tanya B; Pinski, Jacek K; Quinn, David I.

Affiliation

Thara E; Division of Cancer Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

Maturitas ; 69(4): 296-303, 2011 Aug.

Article in En | MEDLINE | ID: mdl-21621934

Subject(s)

Cancer Vaccines; Immunotherapy, Active; Prostatic Neoplasms/therapy; Tissue Extracts; Acid Phosphatase; Cancer Vaccines/immunology; Dendritic Cells; Disease Progression; Granulocyte-Macrophage Colony-Stimulating Factor/immunology; Humans; Kaplan-Meier Estimate; Male; Prostatic Neoplasms/immunology; Protein Tyrosine Phosphatases/immunology; Tissue Extracts/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Tissue Extracts / Immunotherapy, Active / Cancer Vaccines Limits: Humans / Male Language: En Journal: Maturitas Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google